Journal article · 2013
Negative symptoms in schizophrenia – the remarkable impact of inclusion definitions in clinical trials and their consequences
Schizophrenia Research, 150(2-3), 334–338 · Published 29 June 2013 · DOI 10.1016/j.schres.2013.06.023
In brief
“Negative symptoms in schizophrenia – the remarkable impact of inclusion definitions in clinical trials and their consequences” is a 2013 journal article by Jonathan Rabinowitz and 7 co-authors, published in Schizophrenia Research. OpenAlex counts 92 citations as of 20 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 92
- Most cited in
- 2022 (14)
- Field-weighted impact
- 1.91
- References
- 12
- Authors
- 8
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Rabinowitz, J., Werbeloff, N., Caers, I., Mandel, F. S., Stauffer, V. L., Ménard, F., Kinon, B. J., & Kapur, S. (2013). Negative symptoms in schizophrenia – the remarkable impact of inclusion definitions in clinical trials and their consequences. Schizophrenia Research, 150(2-3), 334–338. https://doi.org/10.1016/j.schres.2013.06.023
MLA 9
Rabinowitz, Jonathan, et al. “Negative symptoms in schizophrenia – the remarkable impact of inclusion definitions in clinical trials and their consequences.” Schizophrenia Research, vol. 150, no. 2-3, 2013, pp. 334–338. https://doi.org/10.1016/j.schres.2013.06.023.
Chicago
Rabinowitz, Jonathan, Nomi Werbeloff, Ivo Caers, Francine S. Mandel, Virginia L. Stauffer, François Ménard, Bruce J. Kinon, and Shitij Kapur. 2013. “Negative symptoms in schizophrenia – the remarkable impact of inclusion definitions in clinical trials and their consequences.” Schizophrenia Research 150 (2-3): 334–338. https://doi.org/10.1016/j.schres.2013.06.023.
Harvard
Rabinowitz, J. et al. (2013) ‘Negative symptoms in schizophrenia – the remarkable impact of inclusion definitions in clinical trials and their consequences’, Schizophrenia Research, 150(2-3), pp. 334–338. doi:10.1016/j.schres.2013.06.023.
IEEE
J. Rabinowitz et al., “Negative symptoms in schizophrenia – the remarkable impact of inclusion definitions in clinical trials and their consequences,” Schizophrenia Research, vol. 150, no. 2-3, pp. 334–338, 2013, doi: 10.1016/j.schres.2013.06.023.
BibTeX
@article{rabinowitz2013negative,
title = {{Negative symptoms in schizophrenia – the remarkable impact of inclusion definitions in clinical trials and their consequences}},
author = {Rabinowitz, Jonathan and Werbeloff, Nomi and Caers, Ivo and Mandel, Francine S. and Stauffer, Virginia L. and Ménard, François and Kinon, Bruce J. and Kapur, Shitij},
journal = {Schizophrenia Research},
year = {2013},
volume = {150},
number = {2-3},
pages = {334--338},
doi = {10.1016/j.schres.2013.06.023},
url = {https://doi.org/10.1016/j.schres.2013.06.023}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2017 | 4 | |
| 2018 | 11 | |
| 2019 | 4 | |
| 2020 | 9 | |
| 2021 | 6 | |
| 2022 | 14 | |
| 2023 | 7 | |
| 2024 | 9 | |
| 2025 | 12 | |
| 2026 | 5 |
Its field-weighted citation impact is 1.91: it has been cited 1.91 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- negative symptoms
- schizophrenia
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Rabinowitz, J., Werbeloff, N., Caers, I., Mandel, F. S., Stauffer, V. L., Ménard, F., Kinon, B. J., & Kapur, S. (2013). Negative symptoms in schizophrenia – the remarkable impact of inclusion definitions in clinical trials and their consequences. Schizophrenia Research, 150(2-3), 334–338. https://doi.org/10.1016/j.schres.2013.06.023
How many times has this paper been cited?
92 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Jonathan Rabinowitz, Nomi Werbeloff, Ivo Caers, Francine S. Mandel, Virginia L. Stauffer, François Ménard, Bruce J. Kinon, Shitij Kapur.
What is the DOI of this paper?
10.1016/j.schres.2013.06.023, permanently at https://doi.org/10.1016/j.schres.2013.06.023. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.